• Profile
Close

Vascular access placement order and outcomes in hemodialysis patients: A longitudinal study

American Journal of Nephrology Sep 24, 2017

Murea M, et al. - Longitudinal transitions between tunneled central venous catheters (TCVC)-based and arteriovenous accesses (AVA)-based hemodialysis (HD) outcomes were analyzed as per placement order. Researchers observed that on the basis of the sequence of placement, HD vascular access outcomes differed. Despite frequent AVA placements, only half of patients effectively achieved a “permanent” vascular access and used an AVA for the majority of HD treatments.

Methods

  • This study included 391 patients initiating chronic HD via a TCVC between 2012 and 2013 at 12 outpatient academic dialysis units.
  • Over a mean (SD) of 2.8 (0.9) years, chronological distributions of HD vascular accesses were recorded and then sequentially grouped into periods for TCVC-delivered and AVA-delivered (AVF or AVG) HD.
  • On the basis of access placement sequence and type, adjusting for age, primary AVA failure and cumulative access survival were assessed.

Results

  • Data reported 497 AVA placement surgeries in 92.3% (361/391) of patients.
  • The analysis of the initial 3 surgeries revealed that primary AVF failure rates increased with each successive fistula placement (p = 0.008).
  • Findings demonstrated that among the 82.9% (324/391) of TCVC patients successfully converted to an AVA, 30.9% returned to a TCVC, followed by a 58.0% conversion rate to another AVA.
  • It was also reported that annual per-patient vascular access transition rates were 2.02 (0.09) HD periods using a TCVC and 0.54 (0.03) HD periods using an AVA.
  • In addition, comparing the first AVA used with the second, cumulative access survivals were 701.0 (370.0) vs. 426.5 (275.0) days, respectively.
  • Researchers observed that, excluding those never converting to an AVF or AVG, 169 (52.2%) subsequently converted from a TCVC to a permanent access and received HD via AVA for ≥80% of treatments.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay